Spyre Therapeutics appoints Kate Tansey Chevlen as Chief Commercial Officer
Tansey Chevlen previously spent over 17 years at Amgen in multiple leadership roles
Read MoreAppointments and people articles
Feb 6, 2026 | Appointments
Tansey Chevlen previously spent over 17 years at Amgen in multiple leadership roles
Read MoreJan 29, 2026 | Appointments
Haviland was most recently President and CEO of Blueprint Medicines
Read MoreJan 28, 2026 | Appointments
Lefranc has served at Ipsen since 2013, most recently as Senior Vice President
Read MoreJan 27, 2026 | Appointments
Terri and Mark both have extensive life sciences and consulting experience
Read MoreJan 23, 2026 | Appointments
Ryan’s most recent role was Executive VP and US Head of Digital & Innovation at GCI Health
Read MoreJan 16, 2026 | Appointments
Lee previously held senior roles at ImmPACT Bio, Neogene Therapeutics and AstraZeneca
Read MoreJan 15, 2026 | Appointments
Farrell was previously founder and CEO of two NASDAQ-listed companies
Read MoreJan 14, 2026 | Appointments
Leonard was previously Therapeutic Area Lead for Pfizer’s oncology branch
Read MoreJan 13, 2026 | Appointments
Leftheris has held senior scientific roles at Bristol Myers Squibb and Celgene
Read MoreJan 9, 2026 | Appointments
Wettan has served at Gilead for over 14 years
Read MoreDec 11, 2025 | Appointments
Bertozzi received the 2022 Nobel Prize in Chemistry
Read MoreDec 10, 2025 | Appointments
Habib will be president of Promotional Medical Education and Patient Engagement
Read More
